Position in PTCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$76,400,161
-$21,336,429 QoQ
Shares Held
1,121,388
-12.8% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.85945988364419.ToString("F0")%
Shared 0.ToString("F0")%
None 0.14054011635580194.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. PTCT ranks #17 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,400,161 | 1,121,388 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $97,736,590 | 1,286,685 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $71,007,175 | 1,157,034 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $62,259,277 | 1,274,760 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $64,872,487 | 1,273,008 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $57,697,405 | 1,278,188 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $52,274,418 | 1,409,014 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $44,963,301 | 1,470,350 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $43,096,485 | 1,481,488 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $39,310,976 | 1,426,378 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $46,102,591 | 2,057,233 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $134,695,134 | 3,311,904 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $166,914,455 | 3,445,798 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $133,201,352 | 3,489,687 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $224,332,504 | 4,468,775 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $196,767,107 | 4,911,810 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $183,269,107 | 4,912,064 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $194,418,752 | 4,881,214 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $179,093,850 | 4,813,057 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $244,743,044 | 5,789,994 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $259,440,213 | 5,479,202 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $340,314,448 | 5,576,183 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $260,502,686 | 5,572,250 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $274,583,213 | 5,411,573 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $246,273,162 | 5,520,582 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||